[Occupational rhinitis].
Occupational rhinitis (OR) is an inflammatory disease of the nose, which is characterized by intermittent or persistent symptoms, arising out of causes and conditions attributable to a particular work environment and not to stimuli encountered outside the workplace. Its clinical symptoms (nasal congestion, sneezing, rhinorrhea, itching, nasal airflow limitation) are very similar with the symptoms of the allergic rhinitis caused by other (classical) agents. According to the 27/1996 NM Departmental Order, OR in Hungary is a notifiable disease. Despite, between year 1997 and 2009, not even a single case was reported in Hungary. In the last 20 years the only Hungarian reference in this field was published in 2004, in the Textbook of Occupational Medicine, edited by Ungváry. This disease is not unknown in other European countries. It can be produced by both high and low molecular weight agents. For example, according to the publications, its prevalence among bakers can be 18-29%, and among workers with diisocyanates (painters, urethane mould workers) 36-42%. Risk factors are atopy, high concentration and multiple irritant agents in the air of workplace. Atopy has been associated with an increased risk of specific sensitization to a variety of HMW agents. Beside of the clinical and occupational history, objective investigations have to be used as well, for the diagnosis of OR. The gold standard for confirming the diagnosis of OR is the nasal provocation test. Objective methods that can be used for assessing nasal patency during the investigation of OR include rhinomanometry, acoustic rhinometry, peak nasal inspiratory flow, and gravimetry of the nasal secret. The management of the OR needs environmental interventions. These are: increasing the ventilation, decreasing the time of exposure, substitution of the irritant agent, investigation of possible asthma in all workers with OR. Medical treatments are: oral antihistamines, local (nasal) corticosteroids, combined (antihistamine+membrane-stabilizer) eyedrops.
Endre
László
L
Központi MAV Rendelointézet Budapest. endredr@gmail.com
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D004780:Environment, Controlled; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D007221:Industry; D009299:Nasal Provocation Tests; D009784:Occupational Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D012220:Rhinitis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D025363:Rhinomanometry; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D006633:Histamine Antagonists